<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Jundishapur Journal of Natural Pharmaceutical Products">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Jundishapur J Nat Pharm Prod</JournalTitle>
            <Issn>2228-7876</Issn>
            <Volume>16</Volume>
            <Issue>2</Issue>
            <PubDate PubStatus="epublish">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>30</Day>
            </PubDate>
            <journal_id_doi>10.5812/jjnpp.67765</journal_id_doi>
        </Journal>
        <title locale="en_US">Protection Against Blood-Brain Barrier Permeability as a Possible Mechanism for Protective Effects of Thymoquinone Against Sickness Behaviors Induced by Lipopolysaccharide in Rats</title>
        <AuthorList>
            <Author>
                <FirstName>Rahimeh</FirstName>
                <LastName>Bargi</LastName>
                <affiliation locale="en_US">Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Mahmoud</FirstName>
                <LastName>Hosseini</LastName>
                <affiliation locale="en_US">Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Fereshteh</FirstName>
                <LastName>Asgharzadeh</LastName>
                <affiliation locale="en_US">Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Majid</FirstName>
                <LastName>Khazaei</LastName>
                <affiliation locale="en_US">Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Mohammad Naser</FirstName>
                <LastName>Shafei</LastName>
                <affiliation locale="en_US">Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Farimah</FirstName>
                <LastName>Beheshti</LastName>
                <affiliation locale="en_US">Neuroscience Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran, Department of Physiology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran</affiliation>
            </Author>
        </AuthorList>
        <ArticleType>Research Article</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>5</Month>
                <Day>11</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2018</Year>
                <Month>6</Month>
                <Day>9</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2021</Year>
                <Month>3</Month>
                <Day>30</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2021</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Background : Blood-brain barrier (BBB), as well-known protection for the brain, plays an active role in normal homeostasis. It might be changed by a range of inflammatory mediators to have a role in sickness behaviors. Objectives : Regarding the anti-inflammatory effects of thymoquinone (TQ), its protection against BBB permeability, as a possible mechanism for protective effects against sickness behaviors elicited by lipopolysaccharide (LPS), was evaluated in rats. Methods : The animals were grouped as follows and treated (n = 10 in each): (1) control (saline); (2) LPS 1 mg/kg, was injected two hours before behavioral tests for two weeks; (3-5) 2, 5, and 10 mg/kg TQ, respectively was injected 30 min before LPS injection. Open-field (OF), elevated plus-maze (EPM) and Forced Swimming test (FST) were done. Finally, the animals were anesthetized to evaluate for BBB permeability using Evans blue (EB) dye method. Results : Compared with control, LPS decreased the peripheral distance and crossing and also total crossing and distance in OF, (P &lt; 0.01 - P &lt; 0.001). The central crossing and distance and central time in all three treatment groups were more than LPS (P &lt; 0.05 - P &lt; 0.001). LPS also reduced the entries and the time spent in the open arm while increased the time spent in the closed arm in EPM (P &lt; 0.05 - P &lt; 0.001). The effects of LPS were reversed by TQ (P &lt; 0.05 - P &lt; 0.001). In FST, the immobility time and active time were increased and decreased by LPS compared with control (P &lt; 0.001), respectively. In all three TQ-treated groups, the active and climbing times were more while the immobility time was fewer than the LPS (P &lt; 0.05 - P &lt; 0.001). The animals of the LPS group showed more EB dye content in their brain tissue than the control group (P &lt; 0.05 - P &lt; 0.001). TQ significantly reduced EB dye content of the brain tissues (P &lt; 0.05 - P &lt; 0.001). Conclusions : According to this study, protection against BBB permeability as a possible mechanism for the protective effects of TQ against sickness behaviors induced by LPS might be suggested.</abstract>
        <web_url>https://sites.kowsarpub.com/jjnpp/articles/67765.html</web_url>
        <pdf_url>https://jjnpp.kowsarpub.com/cdn/dl/e522d316-914e-11eb-af88-3beae39493f4</pdf_url>
        <kwd-group>
            <kwd>Blood-Brain Barrier</kwd>
            <kwd>Thymoquinone</kwd>
            <kwd>Sickness Behavior</kwd>
            <kwd>Lipopolysaccharide</kwd>
        </kwd-group>
    </Article>
</Articles>
